CDKN2A and Miyoshi myopathy: In particular, the homozygous deletion of the CDKN2A locus, which, as stated above, is very common in MM cells, results in the functional inactivation of both the key tumor suppressors controlling the G1/S checkpoint, p53 and RB1 [20].